BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31742469)

  • 1. Design and synthesis of tricyclic terpenoid derivatives as novel PTP1B inhibitors with improved pharmacological property and
    Yang L; Chen F; Gao C; Chen J; Li J; Liu S; Zhang Y; Wang Z; Qian S
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):152-164. PubMed ID: 31742469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice.
    Liu ZQ; Liu T; Chen C; Li MY; Wang ZY; Chen RS; Wei GX; Wang XY; Luo DQ
    Toxicol Appl Pharmacol; 2015 May; 285(1):61-70. PubMed ID: 25796170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, kinetic, molecular dynamics, and hypoglycemic effect characterization of new and potential selective benzimidazole derivatives as Protein Tyrosine Phosphatase 1B inhibitors.
    Campos-Almazán MI; Flores-Ramos M; Hernández-Campos A; Castillo R; Sierra-Campos E; Torgeson K; Peti W; Valdez-Solana M; Oria-Hernández J; Méndez ST; Castillo-Villanueva A; Jiménez-de Jesús H; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem; 2021 Oct; 48():116418. PubMed ID: 34563877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors.
    Ghareb N; El-Sayed NM; Abdelhameed R; Yamada K; Elgawish MS
    Bioorg Chem; 2019 May; 86():322-338. PubMed ID: 30743173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B.
    Ottanà R; Paoli P; Lori G; Adornato I; Previti S; Naß A; Wolber G; Maccari R
    Bioorg Chem; 2019 Nov; 92():103211. PubMed ID: 31491569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
    Eleftheriou P; Geronikaki A; Petrou A
    Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of some tetrazole acetamide derivatives as novel non-carboxylic PTP1B inhibitors.
    Maheshwari N; Karthikeyan C; Bhadada SV; Verma AK; Sahi C; Moorthy NSHN; Trivedi P
    Bioorg Chem; 2019 Nov; 92():103221. PubMed ID: 31499261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 1,3,4-Thiadiazolyl-Containing Thiazolidine-2,4-dione Derivatives as Novel PTP1B Inhibitors with Antidiabetic Activity.
    Li M; Li H; Min X; Sun J; Liang B; Xu L; Li J; Wang SH; Xu X
    J Med Chem; 2024 May; 67(10):8406-8419. PubMed ID: 38723203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of 5-(3-bromo-2-(2,3-dibromo-4,5-dimethoxybenzyl)-4,5-dimethoxybenzylidene)thiazolidine-2,4-dione as a novel potent protein tyrosine phosphatase 1B inhibitor with antidiabetic properties.
    Jiang B; Luo J; Guo S; Wang L
    Bioorg Chem; 2021 Mar; 108():104648. PubMed ID: 33493928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, SAR and docking studies of substituted aryl phenylthiazolyl phenylcarboxamide as potential protein tyrosine phosphatase 1B (PTP1B) inhibitors.
    Varshney K; Gupta AK; Rawat A; Srivastava R; Mishra A; Saxena M; Srivastava AK; Jain S; Saxena AK
    Chem Biol Drug Des; 2019 Jul; 94(1):1378-1389. PubMed ID: 30903642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
    Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
    ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of oleanolic acid derivatives: In vitro, in vivo and in silico studies for PTP-1B inhibition.
    Ramírez-Espinosa JJ; Rios MY; Paoli P; Flores-Morales V; Camici G; de la Rosa-Lugo V; Hidalgo-Figueroa S; Navarrete-Vázquez G; Estrada-Soto S
    Eur J Med Chem; 2014 Nov; 87():316-27. PubMed ID: 25264584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking Assisted Prediction and Biological Evaluation of Sideritis L. Components with PTP1b Inhibitory Action and Probable Anti-Diabetic Properties.
    Eleftheriou P; Therianou E; Lazari D; Dirnali S; Micha A
    Curr Top Med Chem; 2019; 19(5):383-392. PubMed ID: 30806317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.
    Maeda A; Kai K; Ishii M; Ishii T; Akagawa M
    Mol Nutr Food Res; 2014 Jun; 58(6):1177-89. PubMed ID: 24668740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel PTP1B inhibitors with antihyperglycemic activity.
    Liu Z; Chai Q; Li YY; Shen Q; Ma LP; Zhang LN; Wang X; Sheng L; Li JY; Li J; Shen JK
    Acta Pharmacol Sin; 2010 Aug; 31(8):1005-12. PubMed ID: 20686525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Acyl-3-carboxyl-tetrahydroisoquinoline Derivatives: Mixed-Type PTP1B Inhibitors without PPARγ Activation.
    Morishita K; Shoji Y; Fukui M; Ito Y; Kitao T; Ozawa SI; Hirono S; Shirahase H
    Chem Pharm Bull (Tokyo); 2018; 66(12):1131-1152. PubMed ID: 30504630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trivaric acid, a new inhibitor of PTP1b with potent beneficial effect on diabetes.
    Sun W; Zhang B; Zheng H; Zhuang C; Li X; Lu X; Quan C; Dong Y; Zheng Z; Xiu Z
    Life Sci; 2017 Jan; 169():52-64. PubMed ID: 27871946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.